Clinical trial
Interstitial Myocardial Fibrosis in Repaired Tetralogy of Fallot: Assessment by Molecular and Imaging Biomarkers and Association With Adverse Events ( Myocardial FIbrosis in Repaired Tetralogy of FAllot- FIFA Study)
NCT04737135 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interstitial Myocardial Fibrosis in Repaired Tetralogy of Fallot: Assessment by Molecular and Imaging Biomarkers and Association With Adverse Events ( Myocardial FIbrosis in Repaired Tetralogy of FAllot- FIFA Study)
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- July 9, 2018
- Completion date
- December 31, 2026
- Enrollment
- 224 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
congenital heart defect, congenital heart disease, fallot tetralogy